{"id":"administration-of-azithromycin-on-day-1","safety":{"commonSideEffects":[{"rate":"5-10","effect":"Gastrointestinal disturbance (nausea, diarrhea, abdominal pain)"},{"rate":"1-3","effect":"Headache"},{"rate":"1-3","effect":"Vaginitis"},{"rate":"rare","effect":"QT prolongation"},{"rate":"rare","effect":"Hepatotoxicity"}]},"_chembl":{"chemblId":"CHEMBL5864823","moleculeType":null,"molecularWeight":"381.48"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Azithromycin binds to the bacterial 50S ribosomal subunit and inhibits transpeptidation and translocation, thereby preventing peptide bond formation and halting protein synthesis. This bacteriostatic action is effective against a broad spectrum of gram-positive and gram-negative bacteria, as well as atypical organisms. The drug accumulates in tissues and has a long half-life, allowing for convenient dosing schedules.","oneSentence":"Azithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:19:38.813Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial infections (respiratory tract, skin and soft tissue, sexually transmitted infections)"},{"name":"Atypical infections (Mycoplasma, Chlamydia, Legionella)"}]},"trialDetails":[{"nctId":"NCT04185402","phase":"PHASE4","title":"Azithromycin Reduction to Reach Elimination of Trachoma","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2021-05-29","conditions":"Trachoma","enrollment":3931},{"nctId":"NCT05994742","phase":"PHASE3","title":"An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM","status":"ACTIVE_NOT_RECRUITING","sponsor":"Queen Mary University of London","startDate":"2024-07-15","conditions":"Severe Acute Malnutrition, HIV, Comorbidities and Coexisting Conditions","enrollment":674},{"nctId":"NCT06289647","phase":"PHASE4","title":"Azithromycin Reduction to Reach Elimination of Trachoma B","status":"WITHDRAWN","sponsor":"University of California, San Francisco","startDate":"2024-10","conditions":"Trachoma","enrollment":""},{"nctId":"NCT03083197","phase":"PHASE4","title":"Scrub Typhus Antibiotic Resistance Trial","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2017-10-15","conditions":"Scrub Typhus","enrollment":177},{"nctId":"NCT07306234","phase":"PHASE4","title":"Doxycycline vs. Macrolide for MRMP (DOMINO)","status":"NOT_YET_RECRUITING","sponsor":"Young June Choe","startDate":"2026-03-01","conditions":"Mycoplasma Pneumoniae, Mycoplasma Pneumoniae Pneumonia","enrollment":208},{"nctId":"NCT06468462","phase":"PHASE4","title":"Periodic Presumptive Treatment vs. doxyPEP for STI Control in Kenyan MSM","status":"RECRUITING","sponsor":"University of Washington","startDate":"2025-10-29","conditions":"Gonorrhea Male, Chlamydia (Male), Syphilis Male","enrollment":2900},{"nctId":"NCT07064278","phase":"NA","title":"Combined Diagnostic Approach for Refractory Mycoplasma Pneumonia in Children","status":"COMPLETED","sponsor":"Children's Hospital of Hebei Province","startDate":"2022-12-01","conditions":"Refractory Mycoplasma Pneumoniae Pneumonia","enrollment":260},{"nctId":"NCT03162497","phase":"PHASE4","title":"Effect of Topical Azithromycin on Tear Film Thickness in Patients With Meibomian Gland Dysfunction","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2018-01-08","conditions":"Dry Eye Syndromes, Meibomian Gland Dysfunction","enrollment":23},{"nctId":"NCT04198649","phase":"PHASE3","title":"Effect of Azithromycin on Failure Proportion of Severe Periodontitis Non-surgical Treatment","status":"TERMINATED","sponsor":"University Hospital, Strasbourg, France","startDate":"2021-11-02","conditions":"Severe Chronic Periodontitis","enrollment":6},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT04527016","phase":"PHASE4","title":"Airway Microbiota Based Treatment of Asthma in Preschool Children","status":"COMPLETED","sponsor":"Children's Hospital of Fudan University","startDate":"2021-10-18","conditions":"Asthma in Children","enrollment":120},{"nctId":"NCT05966688","phase":"PHASE1","title":"A Study to Evaluate the Effect of Co-administration on the Pharmacokinetics of SPR720, Azithromycin, and Ethambutol in Healthy Participants","status":"COMPLETED","sponsor":"Spero Therapeutics","startDate":"2023-08-04","conditions":"Healthy Volunteers","enrollment":39},{"nctId":"NCT03160638","phase":"PHASE2","title":"Azithromycin as Host-directed Therapy for Pulmonary Tuberculosis","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2018-02-01","conditions":"Tuberculosis, Pulmonary","enrollment":24},{"nctId":"NCT04381936","phase":"PHASE3","title":"Randomised Evaluation of COVID-19 Therapy","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2020-03-19","conditions":"Severe Acute Respiratory Syndrome","enrollment":70000},{"nctId":"NCT04458948","phase":"PHASE2","title":"Non-comparative Trial of the Combination of HCQ and AZI in the Treatment of ICU Patients","status":"TERMINATED","sponsor":"University of New Mexico","startDate":"2020-03-24","conditions":"COVID-19","enrollment":28},{"nctId":"NCT03341273","phase":"NA","title":"Placebo-Controlled Trial of Antibiotic Therapy in Adults With Suspect Lower Respiratory Tract Infection (LRTI) and a Procalcitonin Level","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2017-12-08","conditions":"Lower Respiratory Tract Infection","enrollment":514},{"nctId":"NCT04371107","phase":"PHASE3","title":"Proactive Care of Ambulatory COVID19 Patients","status":"SUSPENDED","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2020-04-29","conditions":"Covid19, Azithromycin, Ambulatory","enrollment":11},{"nctId":"NCT04613271","phase":"PHASE3","title":"Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia","status":"COMPLETED","sponsor":"Ina-Respond","startDate":"2020-10-15","conditions":"Infectious Disease, SARS-CoV Infection, Covid19","enrollment":130},{"nctId":"NCT03187834","phase":"PHASE4","title":"Antibiotic Resistance and Microbiome in Children Aged 6-59 Months in Nouna, Burkina Faso","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2017-07-04","conditions":"Child Development","enrollment":252},{"nctId":"NCT04336332","phase":"PHASE2","title":"Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19","status":"TERMINATED","sponsor":"Rutgers, The State University of New Jersey","startDate":"2020-04-01","conditions":"SARS-CoV-2, COVID-19","enrollment":75},{"nctId":"NCT03683667","phase":"PHASE2, PHASE3","title":"Protein Plus: Improving Infant Growth Through Diet and Enteric Health","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2018-09-23","conditions":"Stunting, Malnutrition; Protein, Enteric Pathogens","enrollment":5283},{"nctId":"NCT03098485","phase":"NA","title":"Healthy Patients & Effect of Antibiotics","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2017-01","conditions":"Microbiota, Anti-bacterial Agents","enrollment":20},{"nctId":"NCT03570814","phase":"PHASE4","title":"Cluster RCT of Co-administration Azithromycin, Albendazole & Ivermectin","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2021-12-01","conditions":"Trachoma, Lymphatic Filariases","enrollment":13511},{"nctId":"NCT04354428","phase":"PHASE2, PHASE3","title":"Treatment for COVID-19 in High-Risk Adult Outpatients","status":"TERMINATED","sponsor":"University of Washington","startDate":"2020-04-16","conditions":"COVID-19, SARS-CoV-2","enrollment":289},{"nctId":"NCT05302947","phase":"","title":"COVID-19 Study at the Russian Clinical and Research Center of Gerontology of the Pirogov RNRMU","status":"COMPLETED","sponsor":"Pirogov Russian National Research Medical University","startDate":"2020-02-01","conditions":"COVID-19, Mild to Moderate","enrollment":154},{"nctId":"NCT04338698","phase":"PHASE3","title":"Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT","status":"COMPLETED","sponsor":"Shehnoor Azhar","startDate":"2020-04-22","conditions":"COVID 19","enrollment":550},{"nctId":"NCT05118984","phase":"PHASE4","title":"Efficacy of Azithromycin in MSAF Cases to Improve Maternal and Neonatal Outcomes","status":"COMPLETED","sponsor":"Cairo University","startDate":"2021-02-16","conditions":"Meconium Stained, Azithromycin, Postpartum Endometritis","enrollment":324},{"nctId":"NCT05026801","phase":"PHASE3","title":"Azithromycin Plus Hydroxychloroquine for COVID-19 Infection","status":"WITHDRAWN","sponsor":"Iterum Therapeutics, International Limited","startDate":"2021-02-08","conditions":"Respiratory Tract Infection Viral","enrollment":""},{"nctId":"NCT04354597","phase":"NA","title":"Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients","status":"WITHDRAWN","sponsor":"King Hussein Cancer Center","startDate":"2020-05-01","conditions":"COVID-19","enrollment":""},{"nctId":"NCT04346693","phase":"PHASE3","title":"An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19","status":"COMPLETED","sponsor":"Burnasyan Federal Medical Biophysical Center","startDate":"2020-04-08","conditions":"Acute Respiratory Tract Infection, Acute Respiratory Insufficiency, Pneumonia","enrollment":320},{"nctId":"NCT04869579","phase":"PHASE2","title":"Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients.","status":"UNKNOWN","sponsor":"CHRISTUS Health","startDate":"2021-08-15","conditions":"Covid19","enrollment":100},{"nctId":"NCT04394377","phase":"PHASE4","title":"Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial","status":"COMPLETED","sponsor":"Brazilian Clinical Research Institute","startDate":"2020-06-21","conditions":"Coronavirus Infection","enrollment":615},{"nctId":"NCT04335552","phase":"PHASE2","title":"Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection","status":"TERMINATED","sponsor":"Duke University","startDate":"2020-04-17","conditions":"SARS-CoV-2","enrollment":11},{"nctId":"NCT04871633","phase":"NA","title":"Effectiveness of Remedesvir in COVID-19 Patients Presenting at Mayo Hospital Lahore","status":"COMPLETED","sponsor":"King Edward Medical University","startDate":"2020-08-01","conditions":"COVID-19","enrollment":66},{"nctId":"NCT04160026","phase":"PHASE4","title":"Acceptability and Feasibility in the Context of the IMPROVE Trial in Kenya","status":"COMPLETED","sponsor":"Liverpool School of Tropical Medicine","startDate":"2019-11-11","conditions":"Malaria in Pregnancy, Adherence, Treatment","enrollment":1600},{"nctId":"NCT04150250","phase":"PHASE2","title":"Cholera Anti-Secretory Treatment Trial","status":"COMPLETED","sponsor":"PATH","startDate":"2019-11-04","conditions":"Cholera","enrollment":47},{"nctId":"NCT04386447","phase":"PHASE2","title":"Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19","status":"WITHDRAWN","sponsor":"Azienda Ospedaliero-Universitaria di Parma","startDate":"2020-09-01","conditions":"Covid-19, Corona Virus Infection, SARS-CoV 2","enrollment":""},{"nctId":"NCT04047849","phase":"PHASE4","title":"Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA","status":"RECRUITING","sponsor":"Woman's","startDate":"2019-08-28","conditions":"Rupture of Membranes; Delayed Delivery (Following Spontaneous Rupture), Rupture of Membranes; Premature, Rupture of Membranes; Premature, Affecting Fetus","enrollment":34},{"nctId":"NCT03608774","phase":"PHASE4","title":"Trial of Azithromycin vs. Doxycycline for the Treatment of Rectal Chlamydia in MSM","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2018-07-13","conditions":"Anal Chlamydia Infection","enrollment":177},{"nctId":"NCT04370782","phase":"PHASE4","title":"Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting","status":"COMPLETED","sponsor":"St. Francis Hospital, New York","startDate":"2020-04-28","conditions":"COVID-19","enrollment":18},{"nctId":"NCT04349410","phase":"PHASE2, PHASE3","title":"The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol","status":"COMPLETED","sponsor":"The Camelot Foundation","startDate":"2020-04-11","conditions":"CoVid 19 Positive","enrollment":1800},{"nctId":"NCT04542694","phase":"PHASE3","title":"Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19","status":"COMPLETED","sponsor":"Promomed, LLC","startDate":"2020-05-21","conditions":"COVID-19","enrollment":200},{"nctId":"NCT04463420","phase":"NA","title":"Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19","status":"UNKNOWN","sponsor":"Baqiyatallah Medical Sciences University","startDate":"2020-08-15","conditions":"COVID-19","enrollment":224},{"nctId":"NCT04395768","phase":"PHASE2","title":"International ALLIANCE Study of Therapies to Prevent Progression of COVID-19","status":"UNKNOWN","sponsor":"National Institute of Integrative Medicine, Australia","startDate":"2020-09-09","conditions":"COVID19","enrollment":200},{"nctId":"NCT04530422","phase":"PHASE3","title":"Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment","status":"COMPLETED","sponsor":"Almaza Military Fever Hospital","startDate":"2020-04-15","conditions":"Covid19","enrollment":250},{"nctId":"NCT03386227","phase":"NA","title":"Prophylactic Antibiotics Prior to Embryo Transfer (PAPET): RCT","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2018-01-21","conditions":"Assisted Reproductive Technology, Antibiotic Prophylaxis, Embryo Transfer","enrollment":96},{"nctId":"NCT04502342","phase":"PHASE2","title":"Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients","status":"UNKNOWN","sponsor":"Institute for Research and Development of Medicinal and Food Plants of Guinea","startDate":"2020-06-01","conditions":"Covid19","enrollment":30},{"nctId":"NCT04501965","phase":"PHASE2","title":"Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients","status":"UNKNOWN","sponsor":"Institute for Research and Development of Medicinal and Food Plants of Guinea","startDate":"2020-06-01","conditions":"Covid19","enrollment":231},{"nctId":"NCT04395170","phase":"PHASE2, PHASE3","title":"Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.","status":"UNKNOWN","sponsor":"Lifefactors Zona Franca, SAS","startDate":"2020-09","conditions":"Coronavirus Disease 2019 (COVID-19)","enrollment":75},{"nctId":"NCT04461925","phase":"PHASE1, PHASE2","title":"Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs","status":"UNKNOWN","sponsor":"Institute of Cell Therapy","startDate":"2020-05-02","conditions":"COVID-19 Pneumonia","enrollment":30},{"nctId":"NCT04341870","phase":"PHASE2, PHASE3","title":"Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO","status":"SUSPENDED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-04-11","conditions":"COVID19, SARS-CoV-2 Infection","enrollment":27},{"nctId":"NCT04355052","phase":"PHASE3","title":"Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to \"no Treatment\" in SARS CoV 2 Virus","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2020-04-11","conditions":"COVID - 19","enrollment":250},{"nctId":"NCT04328272","phase":"PHASE3","title":"Effectiveness of Hydroxychloroquine in Covid-19 Patients","status":"UNKNOWN","sponsor":"Prof. Dr. Umar Farooq","startDate":"2020-03-28","conditions":"COVID19","enrollment":75},{"nctId":"NCT02775617","phase":"PHASE4","title":"Azithromycin - Ivermectin Mass Drug Administration for Skin Disease","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2016-07","conditions":"Scabies, Yaws, Impetigo","enrollment":1291},{"nctId":"NCT03960216","phase":"NA","title":"Effects of Periodontal Therapy in Patients With Metabolic Syndrome","status":"COMPLETED","sponsor":"Universidad Complutense de Madrid","startDate":"2012-11-28","conditions":"Periodontitis, Metabolic Syndrome","enrollment":60},{"nctId":"NCT03676140","phase":"PHASE3","title":"Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )","status":"COMPLETED","sponsor":"Lihir Medical Centre","startDate":"2018-10-01","conditions":"Trachoma, Yaws, Lymphatic Filariases","enrollment":20000},{"nctId":"NCT01712711","phase":"PHASE2","title":"Helicobacter Pylori Eradication in Diabetic Subjects With Non-alcoholic Fatty Liver Disease","status":"COMPLETED","sponsor":"Tehran University of Medical Sciences","startDate":"2012-09","conditions":"Non-alcoholic Fatty Liver Disease","enrollment":40},{"nctId":"NCT01654549","phase":"PHASE2","title":"Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic Steatohepatitis","status":"COMPLETED","sponsor":"Tehran University of Medical Sciences","startDate":"2012-04","conditions":"Non-alcoholic Fatty Liver Disease","enrollment":40},{"nctId":"NCT03571230","phase":"PHASE4","title":"Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2018-07-01","conditions":"Helicobacter Pylori Infection, Antimicrobial Susceptibility Testing","enrollment":400},{"nctId":"NCT00549445","phase":"","title":"Effect of Macrolide Antibiotics on Airway Inflammation in People With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2007-08","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":53},{"nctId":"NCT01797107","phase":"PHASE2","title":"Study to Determine the Effect of Azasite on Corneal Surface Irregularity","status":"WITHDRAWN","sponsor":"Philadelphia Eye Associates","startDate":"2013-03","conditions":"Meibomian Gland Dysfunction","enrollment":""},{"nctId":"NCT02830230","phase":"NA","title":"\"Performance of HPV DNA Test in Presence of Co-infection With Common RTIs\"","status":"UNKNOWN","sponsor":"Tata Memorial Hospital","startDate":"2016-07","conditions":"Cervical Inflammation and Human Papilloma Virus Performance","enrollment":508},{"nctId":"NCT02269644","phase":"PHASE3","title":"A P3 Comparator Trial in Community Acquired Bacterial Pneumonia","status":"WITHDRAWN","sponsor":"Durata Therapeutics Inc., an affiliate of Allergan plc","startDate":"2015-11","conditions":"Community Acquired Pneumonia","enrollment":""},{"nctId":"NCT01915082","phase":"PHASE4","title":"Peri-operative Azithromycin to Improve Early Allograft Function and Outcome After Lung Transplantation","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2013-09","conditions":"Disorder Related to Lung Transplantation","enrollment":70},{"nctId":"NCT01783340","phase":"PHASE1, PHASE2","title":"Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine or Chloroquine/Azithromycin Prophylaxis","status":"WITHDRAWN","sponsor":"Radboud University Medical Center","startDate":"2013-04","conditions":"Malaria, Falciparum","enrollment":""},{"nctId":"NCT00677833","phase":"PHASE2, PHASE3","title":"Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated P. Falciparum Malaria In Children In Africa","status":"COMPLETED","sponsor":"Pfizer","startDate":"2008-06","conditions":"Malaria, Falciparum","enrollment":361},{"nctId":"NCT01903057","phase":"PHASE4","title":"Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis","status":"WITHDRAWN","sponsor":"Emory University","startDate":"2014-02","conditions":"Trachoma, Lymphatic Filariasis","enrollment":""},{"nctId":"NCT00105469","phase":"PHASE3","title":"Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2004-07","conditions":"Bacterial Conjunctivitis","enrollment":743},{"nctId":"NCT01921738","phase":"PHASE2","title":"The Effect of Azithromycin in the Treatment of Chronic Periodontitis","status":"COMPLETED","sponsor":"Isfahan University of Medical Sciences","startDate":"2012-05","conditions":"Chronic Periodontitis","enrollment":80},{"nctId":"NCT01906450","phase":"NA","title":"STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER HIGH SENSITIVE C-REACTIVE PROTEIN. RANDOMIZED CONTROLLED CLINICAL TRIAL.","status":"UNKNOWN","sponsor":"Universidad del Valle, Colombia","startDate":"2013-05","conditions":"Chronic Periodontitis","enrollment":75},{"nctId":"NCT01876108","phase":"PHASE2","title":"The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease","status":"COMPLETED","sponsor":"Tehran University of Medical Sciences","startDate":"2012-07","conditions":"Fatty Liver, Liver Dysfunction, Insulin Resistance","enrollment":100},{"nctId":"NCT01759628","phase":"PHASE2","title":"Helicobacter Pylori Eradication in Subjects With Non-alcoholic Fatty Liver Disease","status":"COMPLETED","sponsor":"Tehran University of Medical Sciences","startDate":"2012-04","conditions":"Non-alcoholic Fatty Liver Disease","enrollment":100},{"nctId":"NCT01271231","phase":"NA","title":"Study on Periodontal Treatment in Diabetic Patients","status":"COMPLETED","sponsor":"Universidad de Antioquia","startDate":"2010-04","conditions":"Diabetes, Gingivitis, Periodontitis","enrollment":90},{"nctId":"NCT01631201","phase":"PHASE2","title":"Safety and Efficacy Study of Rifalazil for the Treatment of Chlamydia Trachomatis Infection in Women","status":"COMPLETED","sponsor":"ActivBiotics Pharma, LLC","startDate":"2012-07","conditions":"Chlamydia Trachomatis Infection","enrollment":82},{"nctId":"NCT01136850","phase":"PHASE3","title":"Intermittent Preventive Treatment With Azithromycin-containing Regimens in Pregnant Women in Papua New Guinea","status":"COMPLETED","sponsor":"University of Melbourne","startDate":"2009-11","conditions":"Malaria in Pregnancy, Sexually Transmitted Infections, Anaemia","enrollment":2793},{"nctId":"NCT01008761","phase":"NA","title":"Trial for the Treatment of Acute Asthma in Wheezy Pre-school Aged Children","status":"UNKNOWN","sponsor":"Janielee Williamson","startDate":"2010-01","conditions":"Asthma","enrollment":440},{"nctId":"NCT01032694","phase":"","title":"Non-Interventional Open Label Prospective Observational Comparative Study On Evaluation Of Compliance Of The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Mild To Moderate Community Acquired Pneumonia","status":"TERMINATED","sponsor":"Pfizer","startDate":"2010-04","conditions":"Community-Acquired Pneumonia","enrollment":30},{"nctId":"NCT00852579","phase":"PHASE3","title":"Effects of Macrolides on Asthma Control","status":"COMPLETED","sponsor":"Euan J Cameron","startDate":"2009-03","conditions":"Asthma","enrollment":77},{"nctId":"NCT00821782","phase":"PHASE1","title":"Evaluation of Bacteria in the Mouth and Throat of Healthy Adults Before and After the Administration of Either Levofloxacin or Azithromycin, Both Antibiotic Medications","status":"COMPLETED","sponsor":"Ortho-McNeil Janssen Scientific Affairs, LLC","startDate":"2006-06","conditions":"Healthy Volunteer","enrollment":143},{"nctId":"NCT01348321","phase":"PHASE2, PHASE3","title":"Comparison of Efficacy of Azithromycin and Levamisole Versus of Azithromycin in in the Treatment of Acne","status":"COMPLETED","sponsor":"Ahvaz Jundishapur University of Medical Sciences","startDate":"2008-11","conditions":"Acne","enrollment":169},{"nctId":"NCT00315601","phase":"PHASE4","title":"Intrapulmonary Pharmacokinetics of Antibiotics","status":"TERMINATED","sponsor":"University of Illinois at Chicago","startDate":"2006-01","conditions":"Healthy","enrollment":35},{"nctId":"NCT00367653","phase":"PHASE3","title":"Azithromycin Plus Chloroquine Versus Mefloquine In the Treatment of Uncomplicated P. Falciparum Malaria.","status":"COMPLETED","sponsor":"Pfizer","startDate":"2006-11","conditions":"Malaria","enrollment":397},{"nctId":"NCT00713999","phase":"NA","title":"Urogenital Schistosomiasis and Sexually Transmitted Infections in Madagascar","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2001-08","conditions":"Sexually Transmitted Infections, Schistosoma Haematobium","enrollment":680}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":59,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Administration of Azithromycin on Day 1","genericName":"Administration of Azithromycin on Day 1","companyName":"London School of Hygiene and Tropical Medicine","companyId":"london-school-of-hygiene-and-tropical-medicine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Azithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. Used for Bacterial infections (respiratory tract, skin and soft tissue, sexually transmitted infections), Atypical infections (Mycoplasma, Chlamydia, Legionella).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}